| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |